An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 14 Sep 2017 Status changed from recruiting to completed.
- 09 Jun 2017 Phase has changed from 3 to 4.
- 05 Jun 2017 Planned number of patients changed from 120 to 34.